Neuropathology in Tourette syndrome

CNS Spectrums

Volumn 4, Issue 3, 1999, Pages 65-74

  Swerdlow, Neal R ^a   Young, Anne B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; COMPULSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NEUROPSYCHIATRY; OBSESSION; PRIORITY JOURNAL; REVIEW;

EID: 0032956865     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900000833     Document Type: Review

References (77)

1. Penny JB, Young AB. Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci. 1983;6:73-94.
2. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci. 1987;10:197-245.
3. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sei USA. 1988;85:5733-5737.
4. Javoy-Agid F, Ruberg M, Taquet H, et al. Biochemical neuropathology of Parkinson's disease. Adv Neural. 1940:189-198.
5. Marsden CD. Motor disorders in basal ganglia disease. Rum Neurobiol. 1984;2:245-250.
6. Krishnan KRR, McDonald WM, Escalona PR, et al. Magnetic resonance imaging of the caudate nuclei in depression. Arch Gen Psychiatry: 1990;49:553-557.
7. Baxter LR, Phelps ME, Mazziolta JC, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry. 1987;44:211-218.
8. Modell JG, Mountz JM, Curtis GC, et al. Neurophysiological dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry. 1989;l:27-36.
9. Castellanos FX. Toward a pathophysiology of attenliondeficit/hyperactivity disorder. Clin Pediatr (Phila). 1997;36:381-393.
10. Rosenberg DR, Ke'siiavan MS, O'Hearn KM, et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry. 1997;54:824-830.
11. Modell JG, Mountz JM, Beresford TP. Basal ganglia/limbic striatal and thalamocortical involvement in craving and loss of control in alcoholism. J Neuropsychialry Clin Neurosci. 1990;2:123-144.
12. Van Paesschen W, Revesz T, Duncan JS, King MD, Connelly A. Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy. Ann Neural. 1997;42:756-766.
13. Csemansky JG, Kerr S, Pruthi R, Prosser ES. Mesolimbic dopamine receptor increases two weeks following hippocampal kindling. Brain Res. 1988;449:357-360.
14. Swerdlow NR. Cortico-striatal substrates of cognitive, motor and sensory gating: speculations and implications for psychological function and dysfunction. In: Panksepp J, ed. Advances in Biological Psychiatry. Vol 2. Greenwich, Conn: JAI Press Inc; 1996:179-208.
15. McElroy SL, Phillips KA, Keck PE Jr. Obsessive compulsive spectrum disorder. J Clin Psychiatry. 1994;55:33-51.
16. Cohen DJ, Leckman JF, Pauls D. Neuropsychiatrie disorders of childhood: Tourelle syndrome as a model. Ada Paediatr. 1997;422:106-111.
17. Leckman JF, Peterson BS. The pathogenesis of Tourelle syndrome: epigenetic factors active in early CNS development. Biol Psychiatry. 1993;34:425-427.
18. Swedo SE, Leonard HL, Garvey M, et al. Pédiatrie autoimmune neuropsychiatrie disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264-271.
19. Palumbo D, Maughan A, Kurlan R. Hypothesis III: Tourelle syndrome is only one of several causes of a developmental basal ganglia syndrome. Arch Neural. 1997;54:475-483.
20. Walkup J. Psychiatry of Tourelle syndrome. CNS Spectrums. 1999;4(2):54-61.
21. Richardson EP. Neuropathological studies of Tourelle syndrome. Adv Neural. 1982;35:83-87.
22. Dewulf A, van Bogaert L. Etudes anatomo-cliniques de syndromes hypercineliques complexes. III. Une observation anatomo-clinique de maladie des tics (Gilles de la Tourelle). Monatsschr Psychiatr Neurol. 1941;104: 53-61.
23. Balthasar K. Über das anatomische substrat der geralisierten Tic-Krankheit (maladie des tics, Gilles de la Tourelle): entwicklungshemmung des corpus strialum. Arch Psychiatr Nenenkr (Berlin). 1957;195:531-5W.
24. Kurlan R. Investigating Tourelle syndrome as a neurologie sequela of rheumatic fever. CNS Spectrums. 1999;4(2):62-67.
25. Haber SN, Wolfer D. Basal ganglia peplidergic staining in Tourelle syndrome: a follow-up study. Adv Neurol. 1992:48:145-150.
26. Haber SN, Kowall NW, Vonsaltel JP, Bird ED, Richardson EP. Gilles de la Tourelle syndrome: a postmortem neuropathological and immunohistochemical study. J Neural Sci. 1986;75:225-241.
27. Singer HS, Hahn IH, Moran TH. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourelle syndrome. Ann Neural. 1991;30:558-562.
28. Singer US. Neurochemical analysis of postmortem cortical and striatal brain tissue in patients with Tourelle syndrome. Ade Neural. 1992;58:135-144.
29. Anderson CM, Pollak ES, Chatterjee D, Leckman JF, Riddle MA, Cohen DJ. Postmortem analysis of subcortical monoamines and amino acids in Tourelle syndrome. Adv Neural. 1992;58:123-133.
30. Pulsl SM, Walshe TM, Romero JA. Carbon monoxide poisoning wilh features of Gilles de la Tourelle syndrome. Arch Neural. 1983;40:443-444.
31. Tarsy D. Movement disorders wilh neuroleptic drug treatment. Psychiatr Clin North Am. 1984;7:453471.
32. Mogenson GJ, Yang CR. The contribution of basal forebrain to limbic-molor integralion and the mediation of motivation \o action. AdvK-cpMedBiol 199195567-290.
33. Leckman JF, Riddle MA, Berreltini WH, el al. Elevaled CSF dynorphin A [1-8] in Tourelle syndrome. Life Sci. 1988;43:2015-2023.
34. Weeks RA, Turjanski N, Brooks DJ. Tourelle syndrome: a disorder of cingulale and orbitofrontal cortex? Q J M. 19%;89:401-408.
35. Sandyk R, Gillman MA. Transienl Gilles de la Tourelle syndrome following alcohol withdrawal. Br J Addict. 1985;80:213-214.
36. Sandy KR. The endogenous opioid system in neurological disorders of the basal ganglia. Life Sci. 1985;37:1655-1663.
37. Baumgardner TL, Singer HS, Denckla MG, et al. Corpus callosum morphology in children wilh Tourelle syndrome and attention deficit hyperactivity disorder. Neurology. 1996;47:477-482.
38. Peterson B, Riddle MA, Cohen DJ, et al. Reduced basal ganglia volumes in Tourelle syndrome using threedimensional reconstruction techniques from magnetic resonance images. Neurology. 1993;43:941-949.
39. Singer HS, Reiss AL, Brown JE, et al. Volumetric MRI changes in basal ganglia of children with Tourelle syndrome. Neurology. 1993;43:950-956.
40. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM. A volumetric MRI study of Gilles de la Tourelle syndrome. Neurology. 1997;49:410-415.
41. Caslellanos FX, Giedd JN, Hamburger SD, Marsh WL, Rapoport JL. Brain morphomelry in Tourelle syndrome: ihe influence of comorbid altenlion-deficil/liyperaclivity disorder. Neurology. 1996;47:1581-1583.
42. Mazziolla JC, Phelps ME. Positron emission tomography studies of the brain. In: Phelps ME, Mazziotta JC, Scheiben HR, eds. Positron Emission Tomography and Autoradiography. New York, NY: Raven Press; 1986:493-580.
43. Braun AR, Stoelter B, Randolph C, el al. The functional neuroanalomy of Tourelle syndrome: an FDG-PET study. I. Regional changes in cerebral glucose metalxJism differentiating patients and controls. Neuropsychopharmacology. 1993;9:277-291.
44. Moriarty J, Costa DC, Schmilz B, Trimble MR, Ell PJ, Rotartson MM. Brain perfusion abnormalilies in Gilles de la Tourelle syndrome, βr J Psychiatry. 1995;167:249-254.
45. Moriarty J, Eapen V, Costa DC, et al. HMPAO SPET does not distinguish obsessive-compulsive and tic syndromes in families multiply affected with Gilles de la Tourelle syndrome. PsycholMed. 1997;27:737-740.
46. Sieg KG, Buckingham D, Gaffney GR, Preston DF, Sieg KG. Tc-99m HMPAO SPECT brain imaging of Gilles de la Tourelle syndrome. Clin Nucl Med. 1993;18:255.
47. Riddle MA, Rasmusson AM, Woods SW, el al. SPECT J imaging of cerebral bloodflow in Tourelle syndrome. 4rf»A'euroJ.1992;58:207-211.
48. Eidelberg D, Moeller JR, Antonini A, el al. The metabolic anatomy of Tourelle syndrome. Neurology. 1997;48:927-934.
49. Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 1994;51:62-70.
50. Pelerson BS, Skudlarski P, Anderson AW, el al. A functional magnetic resonance imaging study of tic suppression in Tourelle syndrome. Arch Gen Psychiatry. 1998;55:326-333.
51. Wong DF, Singer US, Brandt J, el al. D2-like dopamine receptor density in Tourelle syndrome measured by PET. JNuclMed. 1997;38:1243-1247.
52. Syzmanski S, Galiano J, Yokoi F, el al. Basal ganglia dopamine release in Tourelle syndrome. J Nucl Med. 1997;37 (suppl):12P.
53. Malison RT, McDougle CJ, van Dyck CH, el al. [123I] beta-CIT SPECT imaging of striatal dopamine Iransporter binding in Tourelle disorder. Am J Psychiatry. 1995;152:1359-1361.
54. George MS, Robertson MM, Costa DC, et al. Dopamine receptor availability in Tourelle syndrome. Psychiatry Res. 1994;55:193-203.
55. Turjanski N, Sawle GV, Playford ED, el al. PET studies of the presynaptic and postsynaptic dopaminergic systems in Tourelle syndrome. J Neural Neurosurg Psychiatry. 1994;57:688-692.
56. Wolf SS, Jones DW, Knable MB, el al. Tourelle syndrome: prediclion of phenolypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science. 1996;273:1225-1227.
57. Chokka PR, Baker GB, Bornstein RA, de Groot CM. The biochemistry of Tourelle syndrome. Metab Brain Dis. 1995:10:107-124.
58. Leckman JF, Goodman WK, Anderson GM, el al. Cerebrospinal fluid biogenic amines in obsessive-compulsive disorder, Tourelle syndrome, and healthy controls. Neuropsychopharmacology. 1995;12:73-86.
59. De Groot CM, Bomstein RA, Baker GB. Obsessive-compulsive symptom clusters and urinary ainine correlates in Tourelle syndrome. J Nerv Ment Dis. 1995:183:224-230.
60. Chappell P, Riddle M, Anderson G, et al. Enhanced stress responsivily of Tourelle syndrome palienls undergoing lumbar puncture. Biol Psychiatry. 1994;36:35-43.
61. Dursun SM, Farrar G, Handley SL, Rickards H, Betts T, Corbett JA. Elevated plasma kynurenine in Tourelle syndrome. Mol Chem Neuropathol. 1994;21:55-60.
62. Singer HS, Giulano JD, Hansen BH, et al. Antibodies against human putamen in children with Tourelle syndrome. Neurology. 1998;50:1618-1624.
63. Schullz RT, Carter AS, Gladstone M, et al. Visual-motor integration functioning in children with Tourelle syndrome. Neuropsychology. 1998;12:134-145.
64. Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. The Simon effect and attention déficits in Gilles de la Tourelle syndrome and Hunlinglon's disease. Brain. 1995;118:1305-1318.
65. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. The effect of Huntinglon's disease and Gilles de la Tourelle syndrome on the ability to hold and shift atlenlion. Neuropsychologia. 1996;34:843-851.
66. Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. Advance information and movement sequencing in Gilles de la Tourelle syndrome. J Neurol Neurosurg Psychiatry. 1995;58:184-191.
67. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallell M. Sensorimotor gating in boys with Tourelle syndrome and ADHD: preliminary results. Biol Psychiatry. 1996;39:33-41.
68. Färber RI1, Swerdlow NR, Clementz BA. Saccadic performance characteristics and the behavioral neurology of Tourelle syndrome. J Neurol Neurosurg Psychiatry. In press.
69. Swerdlow NR, Magulac M, Filion D, Zinner S. Visuospatial priming and lalenl inhibition in children and adults with Tourelle disorder. Neuropsychology. 1996;10:485-494.
70. Smith SJ, Lees AJ. Abnormalities of the blink reflex in Gilles de la Tourelle syndrome. J Neurol Neurosurg Psychiatry. 1989;52:895-898.
71. de Divitiis E, D'Errico A, Cerillo A. Stereotaclic surgery in Gilles de la Tourelle syndrome. Ada Neurochir (men). 1977;24:73.
72. Hassler R, Dieckmann G. Sterotaxic Ireatmenl of lies and inarticulate cries or coprolalia considered as motor obsessional phenomena in Gilles de la Tourelle disease. Rev Neurol (Paris). 1970;123:89-100.
73. Korzen AV, Pushkov VV, Kharitonov RA, el al. Stereotaxic ihalamotomy in ihe combined Ireatmenl of Gilles de la Tourelle disease. Zh Neiropatol Psikhiatr Im S S Korsakoua. 1991;91:100-101.
74. Robinson D, Wu H, Munne RA, el al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:393-398.
75. Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourelle syndrome: the first two decades. Pediatrics. 1998;102:14-19.
76. Gasser T, Fahn S, Breakefield XO. The autosomal dominanl dystonias. Brain Pathol. 1992;2:297-230.
77. Insel TR. Toward a neuroanatomy of obsessivecompulsive disorder. Arch Gen Psychiatry. 1992;49:739-744.